FROM 8-K

Company

Skye Bioscience, Inc.

Filed

February 20, 2018

Period of Report

February 16, 2018

Accession Number

0001640334-18-000352

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →